Self-management, amitriptyline, and amitripyline plus triamcinolone in the management of vulvodynia

Journal of Women's Health

Volumn 18, Issue 2, 2009, Pages 163-169

  Brown, Candace S ^a,d   Wan, Jim ^a   Bachmann, Gloria ^b   Rosen, Ray ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; DYSGEUSIA; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MCGILL PAIN QUESTIONNAIRE; MONOTHERAPY; PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTAL PAIN; SEDATION; SELF CARE; SEX THERAPY; SEXUAL DYSFUNCTION; SIDE EFFECT; TREATMENT OUTCOME; VULVODYNIA; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS; COGNITIVE THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SELF CARE; TREATMENT OUTCOME; TRIAMCINOLONE; VULVA; YOUNG ADULT;

EID: 59349086107     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0676     Document Type: Article

References (24)

1. Haefner HK, Collins ME, David GC, et al. The vulvodynia guidelines. J Lower Gen Tract Dis 2005;9:40-51.
2. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58:82-88.
3. Bachmann GA, Rosen R, Pinn VW, et al. Vulvodynia: A state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med 2006;51:447-456.
4. Onghena P, Van Houdenhove BV. Antidepressant-induced analgesia in chronic nonmalignant pain: A meta-analysis of 39 placebo controlled studies. Pain 1992;49:205-219.
5. McKay M. Dysesthetic ("essential") vulvodynia: Treatment with amitriptyline. J Reprod Med 1993;38:9-13.
6. Munday PE. Response to treatment in dysaesthetic vulvodynia. J Obstet Gynecol 2001;6:610-613.
7. Reed BD, Caron AM, Gorenflo DW, et al. Treatment of vulvodynia with tricyclic antidepressants: Efficacy and associated factors. J Lower Genital Tract Dis 2006;10:245-251.
8. Pagano R. Vulvar vestibulitis syndrome: An often-unrecognized cause of dyspareunia. Aust NZ J Obstet Gynaecol 1999;39:79-83.
9. Updike GM, Wiesenfeld HC. Insight into the treatment of vulvar pain: A survey of clinicians. Am J Obstet Gynecol 2005;193:1404-1409.
10. Segal D, Tifheret H, Lazer S. Submucous infiltration of betamethasone and lidocaine in the treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 2003;107:105-106.
11. Murina P, Tassan P, Roberts P, et al. Treatment of vulvar vestibulitis with submucous infiltrations of methyprednisolone and lidocaine: An alternative approach. J Reprod Med 2001;46:713-716.
12. Arnold LD, Bachmann GA, Rosen R, et al. Vulvodynia: Characteristics and associations with comorbidity and quality of life. Obstet Gynecol 2006;107:617-624.
13. Abramov L, Wolfman I, David MP. Vaginismus: An important factor in the evaluation and management of vulvar vestibulitis syndrome. Gynecol Obstet Invest 1994;38:194-197.
14. Weijmar Schultz WCM, Gianotten WL, Van der Meijden WI, et al. Behavioral approach with or without surgical intervention for the vulvar vestibulitis syndrome: A prospective randomized and nonrandomized study. J Psychosom Obstet Gynecol 1996;17:143-148.
15. Bergeron S, Brown C, Lord MJ, et al. Physical therapy for vulvar vestibulitis syndrome: A retrospective study. J Sex Mar Ther 2002;28:183-192.
16. Bergeron S, Binik YM, Khalife S, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306.
17. Bergeron S, Khalife S Glazer HI, et al. Surgical and behavioral treatments for vestibulodynia: Two-and-one-half-year follow-up and predictors of outcome. Obstet Gynecol 2008;111:159-166.
18. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: A meta-analytic review. Pain 1992;49:221-230.
19. Vas L, Riley JL III, Price DD. A comparison of placebo effects in clinical analgesia trials versus studies of placebo analgesia. Pain 2002;99:443-452.
20. Melzack R, Katz J. The McGill Pain Questionnaire: Appraisal and current status. In: Turk DC, Melzack R, eds. Handbook of pain assessment. New York: The Guilford Press, 1992:152-168.
21. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975:277-299.
22. Klepac RW, Dowling J, Rocke P, et al. Interview vs. paper and-pencil administration of the McGill Pain Questionnaire. Pain 1981;11:241-246.
23. Wilke DJ, Savedra MC, Holzemer WL, et al. Use of the McGill Pain Questionnaire to measure pain: A meta-analysis. Nurs Res 1990;39:36-41.
24. Peckman BM, Maki DG, Patterson JJ, et al. Focal vulvitis: A characteristic syndrome and cause of dyspareunia: Features, natural history, and management. Am J Obstet Gynecol 1986;154:855-864.